Combining an antiplatelet with oral anticoagulants in stroke patients with AF and cardiovascular disease slightly lowers ...
AS she competes on this year’s series of Strictly Come Dancing, Alex Kingston has revealed a secret cancer battle that left ...
An expert discusses how rilzabrutinib’s covalent reversible binding mechanism provides a favorable safety profile with only manageable grade 1 to 2 toxicities and no cardiovascular or bleeding ...
Classical hematologist Srila Gopal, MD, tackles the unique complexities of treating and researching sickle cell disease and ...
Overview of Platelet Aggregation Devices MarketThe global Platelet Aggregation Devices Market is valued at USD 590.65 Million in 2024 and is projected to reach a value of USD 1086 Million by 2035 at a ...
Previous non-experimental studies suggest an association between paracetamol exposure in the first year of life and subsequent asthma and eczema developing in childhood; however, randomised trials are ...
Rilzabrutinib (Wayrilz; Sanofi) may improve immune thrombocytopenia (ITP) outcomes, enable early intervention, and enhance patient quality of life.
Single dose of avigbagene parvec (FLT201) demonstrates sustained clinical benefit and favorable safety up to two years after withdrawal of prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback